EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS156-01563 
Organism
Homo sapiens 
Tissue/cell
P493-6 
Coordinate
chr10:73729550-73731380 
TF binding sites/motifs
Number: 8             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
MAFFMA0495.3chr10:73730947-73730962GAGCTGAGTCAGCGA-6.05
MAFFMA0495.3chr10:73730947-73730962GAGCTGAGTCAGCGA+6.1
RREB1MA0073.1chr10:73730010-73730030CCCCCCACCACCTCCTCACA+6.43
ZNF263MA0528.1chr10:73730004-73730025CCCTCACCCCCCACCACCTCC-6.08
ZNF263MA0528.1chr10:73730001-73730022TCCCCCTCACCCCCCACCACC-6.22
ZNF263MA0528.1chr10:73731314-73731335TTCCCCCTCCTCTCCTCCCTT-6.29
ZNF263MA0528.1chr10:73731306-73731327TTTCCCGCTTCCCCCTCCTCT-6.71
ZNF263MA0528.1chr10:73731318-73731339CCCTCCTCTCCTCCCTTCCTC-6.83
Number of super-enhancer constituents: 24             
IDCoordinateTissue/cell
SE_00376chr10:73730462-73732061Adipose_Nuclei
SE_00890chr10:73728264-73731541Adrenal_Gland
SE_01702chr10:73729991-73737296Aorta
SE_03170chr10:73728186-73729916Brain_Angular_Gyrus
SE_03170chr10:73730522-73732213Brain_Angular_Gyrus
SE_03943chr10:73728232-73743563Brain_Anterior_Caudate
SE_04798chr10:73727845-73748768Brain_Cingulate_Gyrus
SE_05790chr10:73728054-73748631Brain_Hippocampus_Middle
SE_06730chr10:73728098-73748557Brain_Hippocampus_Middle_150
SE_07761chr10:73727829-73748603Brain_Inferior_Temporal_Lobe
SE_08800chr10:73729847-73730059Brain_Mid_Frontal_Lobe
SE_08800chr10:73730674-73731014Brain_Mid_Frontal_Lobe
SE_26917chr10:73729307-73731848Esophagus
SE_29757chr10:73730465-73732147Fetal_Muscle
SE_31814chr10:73728246-73733811Gastric
SE_36082chr10:73729490-73732112HMEC
SE_36975chr10:73727846-73743322HSMMtube
SE_42457chr10:73728200-73733866Lung
SE_46483chr10:73728109-73731704Osteoblasts
SE_46661chr10:73730789-73731330Ovary
SE_47649chr10:73729670-73730093Pancreas
SE_48621chr10:73729126-73737386Right_Atrium
SE_51872chr10:73730145-73732694Skeletal_Muscle_Myoblast
SE_63666chr10:73729615-73737242HSMM
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr107372978973730000
chr107372961273729735
Enhancer Sequence
ATGCTGGGTG AAGCCCCAGG AGGGGCCGTG AATGCTTCTG CTGGGAACTC CTAGAGTGGC 60
GGCACAGAGA GGGTCTTTGC TGCGAAGGAA CACTCAGAGA GTCTCTGGCT TTCGTGAGGT 120
TATGCCTCAG GAGAGGAGAC ACTTCTCCTT TTCATTCGTT AAACAGAAAT GATATTTGCC 180
ACCTTTTCTT CTCTAAGGCC TAAAGAGATG ACAGAATGCT GCTGGTCCTA CCCTGAGCGC 240
GTGGACTCCA CAGCGGGGTG TGGGGTGGCC CCTGGCAGGC CTGGACGGTT TGTTCTGTGC 300
TTGCCGGTGG ACACGCTTCA GCCCTCTGTC TCTATTGCCC CAAATCTGGC CTGTGGCTGC 360
TGGGCCGCCA CCAGCTTGGA GGGCAGGGTG GGCCCCGGGA GCCCCTGACC ACCAGTGACT 420
TCTTGTCTCC AGCTGCCCTC CGTCCTCTTG ATCCCCCTCA CCCCCCACCA CCTCCTCACA 480
AAGATGGCTG TGTGCTGAGG GACTGTGGCT TCCCTGGGCC CTAGGAAATT TATCACTGAG 540
GTTTCAGAGG ACTCTATGAA AAGGATTTGG AGAAAAAGTG TGGAAAATAA ACAAGCCAGT 600
TCCCAGTTCA GCCTCTCCTG AATGCCGCAA GTAAACAACC ACCTCGGAGG CCAGCCCGGG 660
ATGTTCTTAT TTGGCCTCTG TGGTTACACC TGCCCCCTCC CCGCCCAGTC CCTCCTCCTT 720
AACTTTAAGA GCCTCAAAAG TCAGGGAACA CACCCTCCGC TGGCCAGTCC TTGTGCTGCA 780
GGGACGCTGG TGGCTGGGCA CAGGAGGAAC ATGTATATGG GAGAGAAGAC GGCCGGGGGT 840
CCCAGCTCAG CCCTGCTCCC TCTGAGTCAG TCCCAAGCCT GGACCCTCCC CAGCAGGCAG 900
ACGGTGACGT CTTGGTTGGT TGGTGAGTTT AACTTTGATG GTGCAGAATG ATGAGACTTT 960
TCTCCATTTT GTGGCATCTG AGAAGCTTTG CTTCTTAAAC ATTGCTTTAG GGTGGATAGA 1020
CCAAAGCTAA TTTTCCCGTT ATGTCTCTCC AAGACGGGGC CTACCTGTGA GCAAACCCTC 1080
ATAGATTCAT TTACTTTGTA GGCTACCTGG ACAAAAATGT CAGGTTTCTT TGCTTTGGGC 1140
TGGAGTCCTA TCAGCTCAGG GGTGGTGGTG TAAGGTCACA CCAATGATTT CCAGAAACTC 1200
AAGCACTATT CTGAGTGACT AAGTCTGTGG GATAGGAAGC ACATTTTCCA TCTCTTAATA 1260
ACTTCAATTT ACTTAGTGAC CAACTTTAAA ACCAGGCACC CGGTTAGAAG GGGGAGAGCC 1320
AGGGCTTGGC AGCGGAGGGT CCTCACCTTG CATCCAGGGA GTGGCTGAGG GCCCTTCTCG 1380
TTCTCTGTGG CTGTGCTGAG CTGAGTCAGC GAGCCCTGAA GCCTCTGGGA TTTGGGGAGT 1440
GGGGCACTGC TGGAAGGTTC TGGTTCCTGC TTTGTTCTGC TGCTGCCAGG CTTCTGGAGA 1500
GGGTGGTTGT GGGGTGAGTC CTGCGCTCCG CACGTCCACA TGTTCGTATT CTACATATTG 1560
GGCTTCTGAA AAAAGTTCTG GTTCATAAGA CGGCTTCACA GCTTAGCCGT CTGCAGACCA 1620
GTCTGCAGGT TGATCAGCTT TCTGTCATGT GTGTGCTGTT CCTGTTCACA CATGCTGCGC 1680
CGATGCCCGC CTGTGCCTGT GCCAGCCCCA GCCCACACAG CTACCTGAGA TTTAGCCCTG 1740
GGCATCTCCC CTACCCTTTC CCGCTTCCCC CTCCTCTCCT CCCTTCCTCT CCAGCTGCCT 1800
CGCCATCTGC AAGATTCTGG AAAGTGCTAA 1830